Although the majority of patients with cystic fibrosis have a combination of pulmonary and gastrointestinal symptoms by the time they are one year of age, a significant number are culled from an older ...

Inhaled nitric oxide (NO) is a selective pulmonary vasodilator that significantly reduces the neonatal morbidity and mortality associated with pulmonary hypertension (1,2). Given the cost and need for ...